Murray, J L <br/><br/>
Phase I trial of murine monoclonal antibody 14G2a administered by prolonged intravenous infusion in patients with neuroectodermal tumors.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Jan 1994 
 - 184-93 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0732-183X 
<br/><br/><label>Standard No.: </label>10.1200/JCO.1994.12.1.184  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Animals<br/>Antibodies, Monoclonal--adverse effects<br/>Child<br/>Child, Preschool<br/>Female<br/>Humans<br/>Iodine Radioisotopes<br/>Male<br/>Melanoma--therapy<br/>Mice<br/>Middle Aged<br/>Neuroblastoma--therapy<br/>Osteosarcoma--therapy<br/>Treatment Outcome